Literature DB >> 19615415

Rabies virus glycoprotein expression in Drosophila S2 cells. I: design of expression/selection vectors, subpopulations selection and influence of sodium butyrate and culture medium on protein expression.

Marcos Alexandre Nobre Lemos1, Alexandra Souza Dos Santos, Renato Mancini Astray, Carlos Augusto Pereira, Soraia Attie Calil Jorge.   

Abstract

The cDNA encoding the rabies virus glycoprotein (RVGP) gene was cloned in expression plasmids under the control of the inductive metallothionein promoter. They were designed in order to bear or not a secretion signal (i) and a cDNA coding for the selection hygromycin. These vectors were transfected into S2 cells, cell populations selected and subpopulations were then obtained by reselection with hygromycin. Cell cultures were examined for kinetics of cell growth, detection of RVGP mRNA and expression of RVGP. All cell populations were shown to express the RVGP mRNA upon induction. S2MtRVGPHy cell population, transfected with one vector that contains RGPV gene and selection gene, was shown to express higher amounts of RVGP as evaluated by flow cytometry ( approximately 52%) and ELISA (0.64 microg/10(7)cells at day 7). Subpopulation selection allowed a higher RVGP expression, specially for the S2MtRVGPHy(+) (5.5 microg/10(7)cells at day 7). NaBu treatment leading to lower cell growth and higher RVGP expression allowed an even higher RVGP synthesis by S2MtRVGPHy(+) (8.4 microg/10(7)cells at day 7). SF900II medium leading to a higher S2MtRVGPHy(+)cell growth allowed a higher final RVGP synthesis in this cell culture. RVGP synthesis may be optimized by the expression/selection vectors design, cell subpopulations selection, chromatin exposure and culture medium employed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615415     DOI: 10.1016/j.jbiotec.2009.07.003

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  7 in total

1.  Impact of recombinant Drosophila S2 cell population enrichment on expression of rabies virus glycoprotein.

Authors:  Nayara G L Santos; Mayra P Rocca; Carlos A Pereira; Daniella C Ventini; Ana Lia P Puglia; Soraia A C Jorge; Marcos A N Lemos; Renato M Astray
Journal:  Cytotechnology       Date:  2016-05-23       Impact factor: 2.058

2.  Optimized expression of the antimicrobial protein Gloverin from Galleria mellonella using stably transformed Drosophila melanogaster S2 cells.

Authors:  Jan Zitzmann; Tobias Weidner; Peter Czermak
Journal:  Cytotechnology       Date:  2017-01-28       Impact factor: 2.058

3.  Kinetic studies of recombinant rabies virus glycoprotein (RVGP) cDNA transcription and mRNA translation in Drosophila melanogaster S2 cell populations.

Authors:  R M Astray; S A C Jorge; M A N Lemos; A Y Yokomizo; V L L Boldorini; A L P Puglia; O G Ribeiro; C A Pereira
Journal:  Cytotechnology       Date:  2013-01-23       Impact factor: 2.058

4.  Recombinant respiratory syncytial virus F protein expression is hindered by inefficient nuclear export and mRNA processing.

Authors:  Kelly Huang; Heather Lawlor; Roderick Tang; Randall S MacGill; Nancy D Ulbrandt; Herren Wu
Journal:  Virus Genes       Date:  2010-01-29       Impact factor: 2.198

5.  Identification and characterization of four Drosophila suzukii cellularization genes and their promoters.

Authors:  Ying Yan; Syeda A Jaffri; Jonas Schwirz; Carl Stein; Marc F Schetelig
Journal:  BMC Genet       Date:  2020-12-18       Impact factor: 2.797

6.  Production of Rabies VLPs in Insect Cells by Two Monocistronic Baculoviruses Approach.

Authors:  Thaissa Consoni Bernardino; Renato Mancini Astray; Carlos Augusto Pereira; Vera Lucia Boldorini; Marta Maria Antoniazzi; Simone Gonçalves Silva Jared; Eutimio Gustavo Fernández Núñez; Soraia Attie Calil Jorge
Journal:  Mol Biotechnol       Date:  2021-07-06       Impact factor: 2.695

7.  Single-cell cloning enables the selection of more productive Drosophila melanogaster S2 cells for recombinant protein expression.

Authors:  Jan Zitzmann; Christine Schreiber; Joel Eichmann; Roberto Otmar Bilz; Denise Salzig; Tobias Weidner; Peter Czermak
Journal:  Biotechnol Rep (Amst)       Date:  2018-07-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.